Access the latest issue of Nutraceuticals World and browse our extensive archives to catch up on past articles and features.
Read the full digital edition of Nutraceuticals World, complete with interactive content and enhanced features for an engaging experience.
Join our community! Subscribe to Nutraceuticals World to receive the latest industry news, insights, and updates directly to your mailbox.
Learn about Nutraceuticals World’s mission, vision, and commitment to providing valuable information and resources for the nutraceutical industry.
Discover advertising opportunities with Nutraceuticals World to connect with a targeted audience in the nutraceutical sector.
Review our editorial guidelines for contributions and submissions to ensure your content aligns with our standards.
Read about our commitment to protecting your privacy and how we handle your personal information.
Familiarize yourself with the terms and conditions governing the use of nutraceuticalsworld.com.
Dive into feature articles that provide in-depth analysis and discussions on critical topics within the nutraceutical space.
Access unique content and exclusive interviews with industry leaders and innovators, offering insights into the future of nutraceuticals.
Gain valuable perspectives from suppliers on market trends, challenges, and opportunities within the nutraceutical sector.
Tune in to discussions with industry leaders sharing their perspectives on trends and challenges in the nutraceutical sector.
Stay informed with regular market updates that track the latest trends and developments impacting the nutraceutical industry.
Explore mergers and acquisitions, financial performance, and investment trends shaping the nutraceutical landscape.
Learn about the latest innovations in manufacturing and formulation processes that enhance product quality and efficacy.
Discover new products and ingredients making waves in the nutraceutical market, along with their benefits and applications.
Stay updated on regulatory developments and compliance issues affecting the nutraceutical industry.
Access the latest research findings and studies that inform trends and innovations in nutraceuticals.
Learn about nutraceutical products that support beauty and wellness, focusing on ingredients that address age-related concerns.
Discover nutraceutical solutions aimed at supporting bone, joint, and muscle health for optimal mobility.
Stay informed on products and ingredients promoting cardiovascular health and wellbeing.
Explore nutraceutical options designed to support the health and development of children.
Learn about nutraceutical products that enhance cognitive function and mental clarity.
Discover nutraceutical solutions that boost energy levels and support overall vitality.
Stay updated on ingredients and products promoting eye health and vision wellness.
Explore nutraceutical offerings tailored specifically for men’s health and wellness.
Learn about nutraceuticals that promote relaxation, stress relief, and improved sleep quality.
Stay informed about antioxidant-rich ingredients that combat oxidative stress and promote overall health.
Explore the benefits of green ingredients, including superfoods and their roles in health and wellness.
Learn about the uses and benefits of herbs, botanicals, and mushrooms in the nutraceutical sector.
Discover the health benefits of omega-3s and other nutritional oils for overall wellbeing.
Stay updated on the latest research and products related to probiotics and prebiotics.
Explore the role of protein and fiber in nutrition and their importance in dietary supplements.
Learn about alternative sweeteners and their applications in the nutraceutical market.
Discover essential vitamins and minerals that support health and wellbeing in various products.
Access our buyer’s guide to find trusted suppliers and service providers in the nutraceutical market.
Identify the top companies leading the nutraceutical industry with innovative products and solutions.
Explore the capabilities of leading nutraceutical companies and their areas of expertise.
Familiarize yourself with key terms and definitions related to the nutraceutical industry.
Access comprehensive eBooks covering various topics in nutraceuticals, from formulation to marketing.
Watch informative videos featuring industry experts discussing trends, innovations, and insights in nutraceuticals.
Enjoy short, engaging videos that provide quick insights and updates on key nutraceutical topics.
Read in-depth whitepapers that examine key issues, trends, and research findings in the nutraceutical industry.
Explore informational brochures that provide insights into specific products, companies, and market trends.
Access sponsored articles and insights from leading companies in the nutraceutical sector.
Stay informed with the latest news releases and announcements from companies in the nutraceutical industry.
Browse job opportunities in the nutraceutical sector, connecting you with potential employers.
Discover major industry events, trade shows, and conferences focused on nutraceuticals and dietary supplements.
Participate in informative webinars led by industry experts, covering various topics in nutraceuticals.
Discover exclusive live streams and updates from the hottest events and shows.
What are you searching for?
FDA upped the ante in terms of its Warning Letters related to GMP violations and permissible health claims.
January 2, 2014
By: Todd Harrison
Partner, Venable
The dietary supplement industry in 2013 saw the continuance of old enforcement themes, escalation of ongoing actions and a continued deterioration of the scope of the permissible structure/function claim. This article touches on some of the most revealing topics of FDA enforcement over the past year. In 2013, FDA upped the ante in regard to its issuance of Warning Letters, citing violations of current Good Manufacturing Practice (cGMP) requirements for dietary supplements. In all of 2012, FDA issued approximately 20 Warning Letters, citing dietary supplement cGMP violations. In comparison, from just January to September of 2013, more than 25 dietary supplement firms received Warning Letters referencing cGMP violations. Common citations included failure to establish specifications and failure to take proper steps to assure that component suppliers are meeting specifications. In 2013, in particular, the agency underscored the responsibility of each firm releasing products into the marketplace, whether it manufactures the product itself or not, to know how manufacturing activities are performed and to verify that finished products meet specifications for identity, purity, strength and composition. This requirement essentially holds private label distributors liable for adulteration of a product as a result of cGMP violations, whether or not they are involved in the cGMP operation. As such, 2013 saw a significant rise in the number of dietary supplement distributors and marketers auditing their contract manufacturer’s facilities. FDA also amplified its enforcement efforts against companies marketing dietary supplements containing synthetic botanicals in contravention of the agency’s July 2011 New Dietary Ingredient Draft Guidance. Essentially, the draft guidance stated that synthetic copies of botanical constituents are not dietary ingredients permitted for use in supplements. In what was an unexpected leapfrog of the federal rulemaking process, prior to finalization of the guidance, FDA began to enforce the “non-binding,” “Draft—Not for Implementation,” guidance in the spring of 2012 by sending Warning Letters to companies using the ingredient dimethylamylamine (DMAA), known by its common name geranium extract, in their dietary supplements. In addition to continuing the Warning Letter trend, FDA escalated its enforcement of the draft guidance by initiating actions to seize and condemn 1,500 cases of supplements containing DMAA from a GNC warehouse in June 2013. After the actions were filed, however, GNC voluntarily agreed to destroy all DMAA-containing products remaining at the warehouses. In November 2013 the agency again seized more than $2 million worth of DMAA-containing products from Hi-Tech Pharmaceuticals. We expect 2014 to see both a continuation of FDA’s enforcement of its synthetic botanical policy, as well as the long-awaited finalization of the draft guidance. Claims At Issue As in previous years, FDA continued to battle, mostly in Warning Letters, what the agency believes are disease claims made for dietary supplements. Disease claims—those that claim to cure, treat or prevent disease—are impermissible for dietary supplements. While the general theme was the same in 2013, FDA began singing a different tune when it took a special interest in blood sugar and non-specific inflammation claims. FDA issued at least 10 Warning Letters in 2013 to companies for making alleged disease claims correlating dietary supplements to inflammation. Moreover, more than 150 companies—many in the practitioner channel—also received warnings from FDA in the early months of 2013 demanding that the companies discontinue product claims related to inflammation. Based on these actions, the agency may very well consider any mention of “inflammation” a disease claim. While inflammation, in some cases, is connected to well-recognized diseases (e.g., arthritis, pelvic inflammatory disease, etc.), it is also the cornerstone of the human body’s natural healing response. The body uses inflammation to respond to injury, infection or irritants like pollen and dust. In fact, it is the body’s primary mechanism for internal homeostasis, restoring normal structure and function to organs, tissues and cells. Though the industry has long-recognized there is a gray area between an impermissible disease claim and a permissible structure/function claim when it comes to inflammation, 2013 saw a significant increase in the cited violations for inflammation claims thought by many to live unequivocally in the world of permissible structure/function claims. These impermissible disease claims include: “Holm Oak (an ingredient in your product) … [a]nti-inflammatory … properties,” “supports … the body’s natural anti-inflammatory response,” “helps inflammation” and “reduces … inflammation.” Given these cited violations, it appears the agency made a concerted effort to enlarge the scope of impermissible inflammation claims in 2013 to include claims that dietary supplements modify or balance inflammatory responses generally, making such claims de facto drug claims. Similarly, in June and July of 2013, FDA issued nine Warning Letters to companies marketing dietary supplements allegedly making diabetes-related disease claims. However, the claims were not diabetes-specific and, instead, largely centered on generic blood sugar claims like “lower blood sugar” and “sugar balancer.” It is well established that dietary ingredients such as cinnamon, chromium and fibers (e.g., Fenugreek seeds), among others, affect blood sugar in beneficial ways. As with inflammation claims, the agency appears to be demonizing the body’s normal physiological response to nutritional elements. As we move into 2014, developing appropriate structure/function claims related to inflammation and blood sugar, without getting tangled in the impermissible disease claim web, will continue to be a challenge. FDA’s treatment of these two categories of claims as disease claims, and the subsequent classification of these products as unapproved new drugs rather than dietary supplements, serve to further reduce the dwindling pool of permissible claims available to those who wish to advertise their dietary supplement products.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !